Chu WY, Verrest L, Younis BM, Musa AM, et al. Disease-specific differences in pharmacokinetics of paromomycin and miltefosine
between post-kala-azar dermal leishmaniasis and visceral leishmaniasis patients
in eastern Africa. J Infect Dis 2024 Aug 21:jiae413. doi: 10.1093.
PMID: 39166299
|